Ross Stores, Inc. (ROST)
Live price chart, market sentiment, and community perspectives for Ross Stores, Inc. (NASDAQ: ROST).
Live price chart, market sentiment, and community perspectives for Ross Stores, Inc. (NASDAQ: ROST).
Looking at the crowd sentiment on X versus Reddit, there is a massive chasm. X users are running 75% bullish, while Reddit’s r/wallstreetbets sits at 0% and actively bets against the name. With 14 of 19 Wall Street analysts rating ROST a buy and an average target of $254.61, the disconnect between retail short theses and institutional consensus makes this a volatile play heading into the back half of the fiscal year.
From a quantitative risk perspective, Q2 operating profits were heavily skewed by approximately $253 million from IEEPA tariff refunds, which added 405 basis points to the reported operating margin. Excluding this benefit, operating margin growth was still a solid 205 bps, but investors must normalize these non-recurring items when evaluating forward-looking earnings sustainability.
Morningstar’s valuation framework highlights that ROST is trading at a significant premium to their $148 fair value estimate. Even though the off-price model continues to take market share from department stores via self-checkout pilots and social media engagement, stubborn inflation could easily trigger discretionary spending pullbacks, making the current price level vulnerable.
Analyzing the technical setup, the stock recently pulled back toward its 100-day moving average after touching an all-time high of $257.00. While retail traffic remains exceptionally robust and drove total sales up 13% year-over-year to $6.3 billion, the market has already priced in much of the fundamental operational improvements, suggesting a more attractive entry point below $160.
On our options desk, we noted massive bearish positioning ahead of the Q2 earnings release, with 30,000 puts exchanged—about 27 times the intraday average volume—compared to only 5,265 calls. The September 220 put contract saw heavy accumulation as traders targeted the stock amid a pullback from its recent record high of $257.00.
Explore plasma cleansing, somatic organ swaps, and BCI.